Literature DB >> 26100174

Pleuroparenchymal fibroelastosis: Distinct pulmonary physiological features in nine patients.

Satoshi Watanabe1, Yuko Waseda2, Hazuki Takato3, Ryo Matsunuma4, Takeshi Johkoh5, Ryoko Egashira6, Yoshinori Kawabata7, Hiroko Ikeda8, Masahide Yasui9, Masaki Fujimura10, Kazuo Kasahara11.   

Abstract

BACKGROUND: Pleuroparenchymal fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia defined by pleural and subpleural parenchymal fibrosis predominantly in the upper lobes. Although the radiological and pathological characteristics of PPFE have become increasingly recognized, its pulmonary physiological features are not well understood.
METHODS: We reviewed nine patients with radiologically and histologically proven PPFE, and evaluated pulmonary physiological data.
RESULTS: Of the nine patients, six were male and three were female. The median age at presentation was 61 years. Common symptoms were dyspnea on exertion, weight loss, and nonproductive cough. Recurrent pneumothorax was found in eight patients and pneumonia in four. Median pulmonary function test results were as follows: forced vital capacity, 55.4% predicted; total lung capacity (TLC), 67.1% predicted; residual volume (RV), 102.3% predicted; and RV/TLC, 143.6% predicted. RV/TLC was increased without evidence of small airway disease according to clinico-radiologic-pathologic evaluation. The median partial pressure of oxygen in arterial blood and the alveolar-arterial gradient of oxygen were within normal limits, although there was a slightly elevated partial pressure of carbon dioxide in arterial blood (PaCO2). PPFE progressed in all patients despite treatment with pirfenidone, corticosteroids, and immunosuppressive agents. Seven patients died during the follow-up, five because of hypercapnic respiratory failure.
CONCLUSIONS: PPFE is characterized by severe mechanical restriction with high RV/TLC, causing increased PaCO2 and eventual hypercapnic respiratory failure. These physiological findings may be useful as an adjunct in the diagnosis of PPFE.
Copyright © 2015 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Interstitial lung disease; PPFE; Pleuroparenchymal fibroelastosis; Rare idiopathic interstitial pneumonias

Mesh:

Year:  2015        PMID: 26100174     DOI: 10.1016/j.resinv.2015.02.003

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  11 in total

Review 1.  Pleuroparenchymal fibroelastosis (PPFE) treated with lung transplantation and review of the literature.

Authors:  Muhammad Sajawal Ali; Vijaya Sivalingam Ramalingam; George Haasler; Kenneth Presberg
Journal:  BMJ Case Rep       Date:  2019-04-20

2.  Pleuroparenchymal fibroelastosis (PPFE)-like finding on CT in daily practice -prevalence and serial changes.

Authors:  Ryoko Egashira; Ken Yamaguchi; Tetsuya Kondo; Takahiko Nakazono; Shuichi Fukui; Hiroyuki Irie
Journal:  Eur J Radiol Open       Date:  2020-12-02

Review 3.  The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Hiroshi Ishii; Kazuki Nabeshima; Kentato Watanabe
Journal:  Histol Histopathol       Date:  2020-12-14       Impact factor: 2.303

4.  A CARE-compliant case report: Lung transplantation for a Chinese young man with idiopathic pleuroparenchymal fibroelastosis.

Authors:  Hui Huang; Ruie Feng; Shan Li; Bo Wu; Kai Xu; Zuojun Xu; Jingyu Chen
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 5.  Idiopathic Pleuroparenchymal Fibroelastosis.

Authors:  Martina Bonifazi; M Angeles Montero; Elisabetta A Renzoni
Journal:  Curr Pulmonol Rep       Date:  2017-01-27

Review 6.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

7.  Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.

Authors:  Takato Ikeda; Yoshiaki Kinoshita; Yusuke Ueda; Tomoya Sasaki; Hisako Kushima; Hiroshi Ishii
Journal:  J Clin Med       Date:  2020-11-22       Impact factor: 4.241

8.  Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.

Authors:  Makoto Shioya; Mitsuo Otsuka; Gen Yamada; Yasuaki Umeda; Kimiyuki Ikeda; Hirotaka Nishikiori; Koji Kuronuma; Hirofumi Chiba; Hiroki Takahashi
Journal:  Can Respir J       Date:  2018-08-13       Impact factor: 2.409

9.  Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis.

Authors:  Sissel Kronborg-White; Claudia Ravaglia; Alessandra Dubini; Sara Piciucchi; Sara Tomassetti; Elisabeth Bendstrup; Venerino Poletti
Journal:  Respir Res       Date:  2018-07-13

10.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.